Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital... Show more
Marsh & McLennan Companies, Inc. operates primarily through Risk and Insurance Services and Consulting segments, serving clients globally with risk management, insurance broking, reinsurance, and advisory services. Its market leadership stems from established brands such as Marsh and Guy Carpenter, combined with analytics and data insights that differentiate offerings in a competitive landscape. The ongoing transition to the Marsh brand and focus on innovation cycles position the firm for sustained relevance in an industry evolving toward integrated risk and people solutions. Medium-term expansion opportunities arise from cross-selling and geographic diversification, though structural risks include dependency on economic cycles affecting insurance volumes and competition from specialized fintech entrants.
The Q2 2026 earnings report, scheduled for July 21, represents a key near-term catalyst, as investors will scrutinize underlying revenue growth and progress on margin initiatives amid ongoing pricing dynamics in insurance markets. Analyst rating revisions and price target adjustments, with recent activity showing mixed updates from firms such as UBS, Mizuho, and Morgan Stanley, could influence sentiment if consensus shifts toward greater optimism. Capital allocation decisions, including the planned deployment of approximately $5 billion across dividends, acquisitions, and share repurchases in 2026, may support shareholder returns and growth. Strategic partnerships and regulatory developments in reinsurance or consulting could further shape trajectories by expanding service capabilities or altering competitive conditions. These events matter because they provide tangible data points on execution against guidance, potentially affecting valuation multiples and investor positioning.
The professional services sector, particularly insurance brokerage and consulting, responds directly to broader economic conditions. Interest rate movements influence insurance pricing and client risk appetites, while inflation trends can affect operating costs and demand for advisory services. Geopolitical developments and technology adoption, such as AI integration in risk modeling, present both opportunities for efficiency gains and challenges in adapting offerings. Regulatory climates around data privacy, capital requirements, and insurance practices add layers of complexity that could impact compliance costs and market access. Consumer and business demand cycles tied to overall economic expansion remain central to revenue visibility in risk and consulting activities.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. For additional insights, explore the Trend Prediction Engine.
Looking toward 2026 and beyond, Marsh & McLennan Companies, Inc. anticipates underlying revenue growth aligned with prior-year levels, supported by the Thrive program targeting $400 million in savings with reinvestment in talent and AI capabilities. Long-term structural drivers include market expansion through acquisitions, evolution of cost structures via operational efficiencies, and sustainability of margins in the consulting segment led by Oliver Wyman. Technology transitions toward advanced analytics and AI-driven solutions could enhance competitive positioning, while regulatory developments in insurance and consulting may create both compliance demands and new service opportunities. Consensus analyst expectations for adjusted EPS growth, with projections around 6-8% annually, reflect assumptions of steady demand in risk services. Capital allocation priorities emphasizing balanced returns to shareholders alongside growth investments will likely influence long-term sentiment in a sector sensitive to macroeconomic stability.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MRSH has been closely correlated with AON. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRSH jumps, then AON could also see price increases.
| Ticker / NAME | Correlation To MRSH | 1D Price Change % | ||
|---|---|---|---|---|
| MRSH | 100% | -0.39% | ||
| AON - MRSH | 80% Closely correlated | +0.39% | ||
| AJG - MRSH | 75% Closely correlated | -0.26% | ||
| BRO - MRSH | 73% Closely correlated | -0.27% | ||
| WTW - MRSH | 66% Closely correlated | +0.18% | ||
| ERIE - MRSH | 50% Loosely correlated | +1.61% | ||
More | ||||
| Ticker / NAME | Correlation To MRSH | 1D Price Change % |
|---|---|---|
| MRSH | 100% | -0.39% |
| Insurance Brokers/Services industry (20 stocks) | 82% Closely correlated | +2.68% |
| MRSH industry (5 stocks) | 82% Closely correlated | -0.07% |
| Insurance industry (119 stocks) | 60% Loosely correlated | +0.55% |
The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on July 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 30, 2026. You may want to consider a long position or call options on MRSH as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MRSH just turned positive on June 23, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
MRSH moved above its 50-day moving average on June 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 280 cases where MRSH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MRSH moved out of overbought territory on July 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MRSH broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.896) is normal, around the industry mean (6.530). P/E Ratio (22.289) is within average values for comparable stocks, (29.548). Projected Growth (PEG Ratio) (1.723) is also within normal values, averaging (1.713). MRSH has a moderately high Dividend Yield (0.020) as compared to the industry average of (0.014). P/S Ratio (3.187) is also within normal values, averaging (3.361).